Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad26.COV2.S Immunogenicity and Safety in Malian Adults
NCT05409261Phase 2Active, not recruiting
- Sponsor
- ANRS
- Start
- Jun 2022
- Primary completion
- Sep 2022
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Ad26.COV2.S in coronavirus disease 2019 (COVID-19), sponsored by ANRS. Started Jun 2022; status: active, not recruiting.
02
Drugs
Ad26.COV2.S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05409261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05409261.